244-OR: Toward Improved Identification of Adult-Onset Type 1 Diabetes (T1D): Clinical Characteristics Associated with T1D Polygenic Risk Scores in the Million Veteran Program (MVP)

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 244-OR
Author(s):  
PETER K. YANG ◽  
SANDRA JACKSON ◽  
BRIAN R. CHAREST ◽  
MICHAEL N. WEEDON ◽  
YILING J. CHENG ◽  
...  
2018 ◽  
Vol 6 (3) ◽  
pp. 169
Author(s):  
Nicholas J Thomas ◽  
Samuel E Jones ◽  
Michael N Weedon ◽  
Beverley M Shields ◽  
Andrew T Hattersley ◽  
...  

2018 ◽  
Vol 6 (3) ◽  
pp. 168-169 ◽  
Author(s):  
Richard David Leslie ◽  
Åke Lernmark

Diabetes Care ◽  
2000 ◽  
Vol 23 (9) ◽  
pp. 1326-1332 ◽  
Author(s):  
E. Sabbah ◽  
K. Savola ◽  
T. Ebeling ◽  
P. Kulmala ◽  
P. Vahasalo ◽  
...  

Diabetologia ◽  
2021 ◽  
Author(s):  
Nicholas J. Thomas ◽  
John M. Dennis ◽  
Seth A. Sharp ◽  
Akaal Kaur ◽  
Shivani Misra ◽  
...  

Abstract Aims/hypothesis Among white European children developing type 1 diabetes, the otherwise common HLA haplotype DR15-DQ6 is rare, and highly protective. Adult-onset type 1 diabetes is now known to represent more overall cases than childhood onset, but it is not known whether DR15-DQ6 is protective in older-adult-onset type 1 diabetes. We sought to quantify DR15-DQ6 protection against type 1 diabetes as age of onset increased. Methods In two independent cohorts we assessed the proportion of type 1 diabetes cases presenting through the first 50 years of life with DR15-DQ6, compared with population controls. In the After Diabetes Diagnosis Research Support System-2 (ADDRESS-2) cohort (n = 1458) clinician-diagnosed type 1 diabetes was confirmed by positivity for one or more islet-specific autoantibodies. In UK Biobank (n = 2502), we estimated type 1 diabetes incidence rates relative to baseline HLA risk for each HLA group using Poisson regression. Analyses were restricted to white Europeans and were performed in three groups according to age at type 1 diabetes onset: 0–18 years, 19–30 years and 31–50 years. Results DR15-DQ6 was protective against type 1 diabetes through to age 50 years (OR < 1 for each age group, all p < 0.001). The following ORs for type 1 diabetes, relative to a neutral HLA genotype, were observed in ADDRESS-2: age 5–18 years OR 0.16 (95% CI 0.08, 0.31); age 19–30 years OR 0.10 (0.04, 0.23); and age 31–50 years OR 0.37 (0.21, 0.68). DR15-DQ6 also remained highly protective at all ages in UK Biobank. Without DR15-DQ6, the presence of major type 1 diabetes high-risk haplotype (either DR3-DQ2 or DR4-DQ8) was associated with increased risk of type 1 diabetes. Conclusions/interpretation HLA DR15-DQ6 confers dominant protection from type 1 diabetes across the first five decades of life. Graphical abstract


Diabetologia ◽  
2007 ◽  
Vol 50 (11) ◽  
pp. 2276-2279 ◽  
Author(s):  
Y. M. Cho ◽  
J. T. Kim ◽  
K. S. Ko ◽  
B. K. Koo ◽  
S. W. Yang ◽  
...  

Endocrine ◽  
2015 ◽  
Vol 49 (3) ◽  
pp. 693-702 ◽  
Author(s):  
Ananta Poudel ◽  
Omid Savari ◽  
Deborah A. Striegel ◽  
Vipul Periwal ◽  
Jerome Taxy ◽  
...  

2016 ◽  
Vol 40 (2) ◽  
pp. 164-169 ◽  
Author(s):  
Janet Jull ◽  
Holly O. Witteman ◽  
Judi Ferne ◽  
Manosila Yoganathan ◽  
Dawn Stacey

Diabetes Care ◽  
2021 ◽  
Vol 44 (11) ◽  
pp. 2449-2456
Author(s):  
R. David Leslie ◽  
Carmella Evans-Molina ◽  
Jacquelyn Freund-Brown ◽  
Raffaella Buzzetti ◽  
Dana Dabelea ◽  
...  

2001 ◽  
Vol 7 (5) ◽  
pp. 346-351 ◽  
Author(s):  
Pablo-José López-Ibarra ◽  
Ma Mar Campos Pastor ◽  
Fernando Escobar-Jiménez ◽  
Ma Dolores Serrano Pardo ◽  
Antonio García González ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document